FDA Investigator Robert O'brian
Robert O'brian has conducted inspections on 55 sites in 1 countries as of 04 Aug 2005. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
55
Last Inspection Date:
04 Aug 2005
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Robert O'brian:
Abby E Pelletier,
Alan R Condon,
Aldo J Quintana,
Alice C Silva,
Alois P Provost,
Alysia M Salonia,
Amber G Wardwell,
Amy C Jordan,
Andre S Lamontagne,
Andrew M Barlow,
Anthony N Onianwa,
Anthony P Costello,
Anthony W Thomas,
Ashley M Whitehurst,
Asia D Clark,
Atricia L Irons,
Bo Chi, PhD,
Bradley D Newsad,
Brenda P King,
Brenna L Macdowell,
Byungja E Marciante,
Camerson E Moore,
Charlotte Hinkle,
Chiang Syin, PhD,
Christine L Williams,
Christopher K Vantwuyver,
Christopher M Elliott,
Clinton V Giustra,
Constance Desimone,
Cynthia Jim, CSO,
Cynthia Whitmarsh,
Darin S Wiegers,
Daryl A Dewoskin,
David P Vanhouten,
Diane C Thibodeau,
Dien N Nguyen,
Dr. Barbara D Paul, PhD,
Dr. Robert C Horan, MD,
Edmund F Mrak, Jr,
Elise L Mcdevitt,
Ellen P Madigan,
Erin P Conlin,
Frank J Koch,
Garry H Stewart,
Gary J Hagan,
Gerard D Difiore,
Jamie S Mathews,
Jason A Rossi,
John A Sciacchitano,
John P Mistler,
John P Shelton,
John R Carlson,
Jonah S Ufferfilge,
Jonathan G Matrisciano,
Joseph B Cascio,
Joseph Foley,
Joyce A Kellett,
Julie A Finegan,
Justin A Boyd,
Justine M Corson,
Karen Mcnabb Noon,
Kathleen E Mcafoose,
Kenneth H Williams,
Kent A Conforti,
Kristina J Donohue,
Lauren M Lawrance,
Laurie B Frazier,
LCDR Debra Emerson,
Leo B Zadecky,
Li Yun Huang,
Liz M Otero,
Lorayne A Mcguinness,
Lori A Holmquist,
Louis Christy,
Margaret E Walsh,
Mariza M Jafary,
Mark R Mcclain,
Martin J Guardia,
Mary Jeanet Mcgarry,
Matthew C Watson,
Matthew D Silverman,
Maya M Davis,
Megan A Haggerty,
Meredith L Miller,
Michael L Casner,
Michael P Anthony,
Michael P Sweeney,
Michelle M Noe Varga,
Mihaly S Ligmond,
Monique C Lo,
Nancy M Espinal,
Osama A Khatib,
Paraluman S Leonin,
Paul L Bellamy,
Paul P Geraci,
Paula M Laplant,
Philip Kreiter,
Prabhu P Raju,
Ramon E Martinez,
Richard A Abate,
Richard H Penta,
Robert D Ogan,
Robert J Martin,
Rory K Geyer,
Rupa Pradhan,
Sean M Tessicini,
Sean R Marcsisin,
Sherry M Nisson,
Shirley S Wen,
Simone E Pitts,
Slater K Bartlett,
Stacey S Degarmo,
Stephen C King,
Stephen R Souza,
Sunita Pandey,
Susanne M Richardson, MS RAC,
Suzanne M Healy,
Sylvia A Craven,
Teddy Tom,
Terry C Kimball,
Thomas Cote,
Thomas J Arista,
Thomas J Murphy,
Thomas W Nerney,
Timothy M Glod,
Troy R Petrillo,
Victoria M Daddeo,
Victoria Taylor,
Wendy A Johnecheck,
Weston K Szymanski,
William K Dagley,
Ze Peng
Robert O'brian's Documents
Publish Date | Document Type | Title |
---|---|---|
October, 2004 | EIR | Cambridge Isotope Laboratories, Inc. - EIR, 2004-10-20 |
April, 2005 | EIR | Central Admixture Pharmacy Services, Inc. - EIR, 2005-04-20 |
December, 2002 | FDA 483 | Life Supply Corp. - Form 483, 2002-12-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more